$18.850
+0.956 (+5.07%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AVBP por análisis de gráficos similares
Alphio's AVBP stock price prediction model matches the current ArriVent BioPharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.73 (-0.62%). The 1-week path is $18.15 (-3.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de ArriVent BioPharma, Inc.?
Currently, Arrivent Biopharma Inc (AVBP) is not a good buy. The stock has plummeted 48% following a failed clinical trial, and the current price is $16.66, significantly below recent analyst price targets ranging from $18 to $29. The RSI is at a low 25.154, indicating oversold conditions, but the overall financial outlook remains negative with a forward P/E of 0 and a net income loss of $49.89 million in Q2 2026. The main risk is the ongoing negative sentiment due to the trial failure, which has led to a drastic drop in stock price and market confidence.
AVBP cerró en $18.85 el Tuesday, tras subir +5.07%
ArriVent BioPharma, Inc. (AVBP) last closed at $18.85, gaining +5.07%. These facts feed the 1-day and 1-week AVBP price prediction above.
Factores de la previsión
Los factores de la previsión de ArriVent BioPharma, Inc. (AVBP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AVBP, ordenadas por similitud.
Análisis de estacionalidad de AVBP
Historically the probability of a positive October return for AVBP is 42.62%. August offers the highest probability of a positive month at 67.19%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de AVBP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $18.96 | $22.26 | $25.37 | +18.08% |
| Nov 2026 | $26.25 | $26.63 | $29.64 | +41.25% |
| Dec 2026 | $19.79 | $23.49 | $25.85 | +24.63% |
En 2026, se proyecta que ArriVent BioPharma, Inc. (AVBP) oscile entre $18.96 y $29.64.
Previsión mensual de ArriVent BioPharma, Inc. para 2026
En Oct de 2026, se proyecta que ArriVent BioPharma, Inc. promedie $22.26, con un mínimo de $18.96 y un máximo de $25.37.
En Nov de 2026, se proyecta que ArriVent BioPharma, Inc. promedie $26.63, con un mínimo de $26.25 y un máximo de $29.64.
En Dec de 2026, se proyecta que ArriVent BioPharma, Inc. promedie $23.49, con un mínimo de $19.79 y un máximo de $25.85.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.